Toon Laeremans

USPTO Granted Patents = 30 (Patent Applications = 15)

CIPO Patents = 6 (Patent Applications = 2)

EPO Patents = 12 (Patent Applications = 22)

Average Co-Inventor Count = 5.8

ph-index = 4

Forward Citations = 66(Granted Patents)

Location History:

Dworp-Beersel, BE (2015 - 2020)
Dworp, BE (2012 - 2022)

Company Filing History:

16 out of 185

Vrije Universiteit Brussel

Leland Stanford Junior University

Boehringer Ingelheim International Gmbh

patents

6. 3 out of 3,378

University of Michigan

patents

7. 2 out of 4

University Medical Center Hamburg-eppendorf

9. 1 out of 832,812

Other

patents

where one patent can have more than one assignee

Years Active: 2012-2025

Loading Chart...

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12252521 - Binding domains directed against GPCR:G protein complexes and uses derived thereof (2025-03-18),

2. 12221487 - Nucleic acids encoding CX3CR1-binding polypeptides comprising immunoglobulin single variable domains (2025-02-11),

3. 12092646 - Protein binding domains stabilizing functional conformational states of GPCRS and uses thereof (2024-09-17),

4. 11479791 - Tools and methods for expression of membrane proteins (2022-10-25),

5. 11384151 - CX3CR1-binding polypeptides comprising immunoglobulin single variable domains (2022-07-12),

6. 11352422 - Opioid receptor binding agents and uses thereof (2022-06-07),

7. 11162954 - Protein binding domains stabilizing functional conformational states of GPCRs and uses thereof (2021-11-02),

8. 11162953 - Protein binding domains stabilizing functional conformational states of GPCRS and uses thereof (2021-11-02),

9. 10626154 - Binding domains directed against GPCR:G protein complexes and uses derived thereof (2020-04-21),

10. 10544216 - P2X7 receptor antagonists and agonists (2020-01-28),

11. 10436796 - Protein binding domains stabilizing functional conformational states of GPCRs and uses thereof (2019-10-08),

12. 10385134 - CX3CR1-binding polypeptides comprising immunoglobulin single variable domains (2019-08-20),

13. 10233241 - Opioid receptor binding agents and uses thereof (2019-03-19),

14. 10078088 - Protein binding domains stabilizing functional conformational states of GPCRs and uses thereof (2018-09-18),

15. 10054598 - Protein binding domains stabilizing functional conformational states of GPCRs and uses thereof (2018-08-21),

Title: Toon Laeremans: Pioneering Sustainable Innovation

Introduction: Toon Laeremans, a visionary inventor hailing from Dworp, Belgium, embodies the essence of creativity and sustainability in his groundbreaking work. With an impressive portfolio of 27 patents, his commitment to developing a more sustainable future is truly inspiring.

Latest Patents:

1. Tools and methods for expression of membrane proteins: Laeremans' innovative patent focuses on cells expressing membrane proteins and binding domains, enabling enhanced production and characterization of these crucial proteins. These tools hold immense potential for advancing structural studies and drug discovery targeting membrane proteins.

2. CX3CR1-binding polypeptides comprising immunoglobulin single variable domains: This patent highlights Laeremans' expertise in developing polypeptides with specific immunoglobulin domains targeting CX3CR1. The applications of these polypeptides for prophylactic, therapeutic, and diagnostic purposes showcase his versatile approach to impactful innovation.

Career Highlights: Laeremans has left an indelible mark on the innovation landscape through his tenure at respected institutions such as Vib Vzw and Vrije Universiteit Brussel. His dedication to pushing the boundaries of science and sustainability is evident in the transformative nature of his patents.

Collaborations: Collaborating with esteemed coworkers like Jan Steyaert and Els Pardon, Laeremans has fostered a culture of innovation and excellence. Together, they have propelled research and development efforts to new heights, leading to the creation of pioneering solutions with far-reaching impacts.

Conclusion: Toon Laeremans' unwavering commitment to sustainable innovation sets him apart as a trailblazer in the field of invention. His impressive patents, coupled with a stellar career and collaborative spirit, exemplify his enduring legacy that will continue to shape the future of innovation for years to come.

This text is generated by artificial intelligence and may not be accurate.